公开(公告)号：US08581238B2

公开(公告)日：2013-11-12

申请号：US12918691

申请日：2009-02-19

Applicant: Chang Ming Li ,  Jun Li ,  Beng Ong ,  Qin Fang

Inventor： Chang Ming Li ,  Jun Li ,  Beng Ong ,  Qin Fang

IPC: H01L35/24

CPC classification number: H01L51/0036 ,  C07D495/14 ,  C08G61/126 ,  H01L51/0043 ,  H01L51/0545

Abstract: An organic compound represented by the following general formula (I) wherein n is an integer from 1 to 500, inclusive, and R1 and R2 are each independently a moiety having an atom length of from about 8 atoms to about 20 atoms.

Abstract translation: 由以下通式（I）表示的有机化合物，其中n为1至500的整数，包括1和500，并且R 1和R 2各自独立地为原子长度为约8至约20个原子的部分。

公开(公告)号：US20100327273A1

公开(公告)日：2010-12-30

申请号：US12918691

申请日：2009-02-19

Applicant: Chang Ming Li ,  Jun Li ,  Beng Ong ,  Qin Fang

Inventor： Chang Ming Li ,  Jun Li ,  Beng Ong ,  Qin Fang

IPC: H01L51/30 ,  H01L51/40 ,  C07D495/14 ,  C08G73/06

CPC classification number: H01L51/0036 ,  C07D495/14 ,  C08G61/126 ,  H01L51/0043 ,  H01L51/0545

Abstract: An organic compound represented by the following general formula (I) wherein n is an integer from 1 to 500, inclusive, and R1 and R2 are each independently a moiety having an atom length of from about 8 atoms to about 20 atoms.

Abstract translation: 由以下通式（I）表示的有机化合物，其中n为1至500的整数，包括1和500，并且R 1和R 2各自独立地为原子长度为约8至约20个原子的部分。

公开(公告)号：US20100111988A1

公开(公告)日：2010-05-06

申请号：US12443684

申请日：2007-09-29

Applicant: Chengchao Shou ,  Yahui Su ,  Qin Fang

Inventor： Chengchao Shou ,  Yahui Su ,  Qin Fang

IPC: A61K39/00 ,  C07K7/08 ,  C07K7/06 ,  C07K14/00 ,  C07H21/00 ,  C12N15/74 ,  C12N5/071 ,  A61K38/10 ,  A61K38/08 ,  A61K31/7088 ,  A61P35/00

CPC classification number: C07K14/52 ,  A61K38/00 ,  C07K7/08

Abstract: The present invention relates to a small peptide for anti-angiogenesis and use thereof, in particular, to a small peptide useful for treating angiogenesis diseases; a polynucleotide coding the peptide; a vector and a cell comprising the polynucleotide; a pharmaceutical composition comprising the small peptide, the fused peptide or the fused protein, the polynucleotide, the vector and/or the cell. The small peptide, the fused peptide or the fused protein, the polynucleotide, the vector, the cell and/or the pharmaceutical composition can be used for treatment of associated diseases such as tumor by anti-angiogenesis.

Abstract translation: 本发明涉及用于抗血管发生的小肽及其用途，特别涉及可用于治疗血管发生疾病的小肽; 编码该肽的多核苷酸; 载体和包含所述多核苷酸的细胞; 包含小肽，融合肽或融合蛋白，多核苷酸，载体和/或细胞的药物组合物。 小肽，融合肽或融合蛋白，多核苷酸，载体，细胞和/或药物组合物可用于通过抗血管生成治疗相关疾病如肿瘤。